Please login to the form below

Not currently logged in
Email:
Password:

Four Health announces a pair of internal promotions

Richard Springham and Kelly Smith will both take on managing director roles

Four Health has announced the promotion of Richard Springham and Kelly Smith, who are both set to become managing directors within the group.

Richard SpringhamSpringham (pictured left) has more than a decade of experience within the health sector, gained from leading teams within international publishers and the NHS.

Most recently, he spent three years working with some of the world’s largest pharmaceutical companies at Four Health Media, where he started off as an account director and digital lead.

He has won multiple industry awards for his work in digital marketing, and he also has a particular interest in the future of blockchain in the health sector.

As a managing director, Springham will head up Four Health Media – the group's health care professionals media planning and buying specialists.

Kelly SmithSmith (pictured right) is set to head up Four Well Being, a new initiative focused on all aspects of patients and healthcare communications.

She has over 12 years of experience in the industry, having executed both healthcare professional media and patient centric communication campaigns in media and sector specialist publishing.

She also has expertise in reaching healthcare consumers on a multi-channel level.

In addition, Smith has an in-depth knowledge of the nursing and primary care market, after spending eight years at the Royal College of Nursing, and she has also studied the role of the NHS in public health and prevention medicine.

Article by
Lucy Parsons

3rd March 2020

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...